Search Results 41-50 of 16815 for Fibronolytic

  1. A Trial to Evaluate the Safety of Long Term Treatment With Nintedanib in Patients With Scleroderma Related Lung Fibrosis - Mayo Clinic

    Fibrinolysis, full-dose therapeutic anticoagulation; High dose antiplatelet therapy. Hemorrhagic central nervous system (CNS) event after completion of the ...

  2. Fitusiran (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Fitusiran injection is used to prevent or decrease the frequency of bleeding episodes in patients with hemophilia A or B with or without factor VIII or IX ...

  3. Phase 2b Study of Investigational Products in Participants with Interstitial Lung Disease Secondary to Systemic Sclerosis - Mayo Clinic

    The purpose of this study is to evaluate the efficacy of the investigational products (IPs) compared with placebo on the change from baseline to the end of the ...

  4. A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis - Mayo Clinic

    Bleeding risk (such as predisposition to bleeding, fibrinolysis, full-dose anticoagulation, high dose antiplatelet therapy, history of hemorrhagic central ...

  5. A Study to Evaluate the Effectiveness, Safety, and Tolerability of BOS-589 in the Treatment of Patients with Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) - Mayo Clinic

    About this study. The purpose of this study is to evaluate abdominal pain response to BOS-589 in participants with diarrhea-predominant Irritable Bowel ...

  6. https://www.mayoclinic.org/chinese_organization_concepts.xml

  7. Arteriosclerosis / atherosclerosis - Doctors and departments - Mayo Clinic

    Mayo Clinic healthcare professionals perform research to develop new treatments for atherosclerosis. They also study ways to reduce the risk of heart attacks ...

  8. Cardiovascular Medicine - Clinical trials

    Participants in this study will either have heart failure (HF) and are scheduled to undergo cardiac resynchronization therapy pacemaker (CRT-P) or cardiac ...

  9. Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD) - Mayo Clinic

    Known genetic predisposition to bleeding. Patients who require. Fibrinolysis, full-dose therapeutic anticoagulation (e.g. vitamin K antagonists, direct ...

  10. A Follow-up Study to Test Long-term Treatment With BI 1015550 in People With Pulmonary Fibrosis Who Took Part in a Previous Study With BI 1015550 (FIBRONEER™-ON) - Mayo Clinic

    The purpose of this follow-up study is to assess the tolerability, long-term safety, and effectiveness of BI 1015550 in patients with IPF and PPF over a longer ...